1. Home
  2. MBWM vs CBLL Comparison

MBWM vs CBLL Comparison

Compare MBWM & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBWM

Mercantile Bank Corporation

SELL

Current Price

$60.21

Market Cap

1.1B

Sector

Finance

ML Signal

SELL

Logo CeriBell Inc.

CBLL

CeriBell Inc.

SELL

Current Price

$26.31

Market Cap

935.3M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
MBWM
CBLL
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
935.3M
IPO Year
1997
2024

Fundamental Metrics

Financial Performance
Metric
MBWM
CBLL
Price
$60.21
$26.31
Analyst Decision
Hold
Strong Buy
Analyst Count
6
8
Target Price
★ $64.17
$31.57
AVG Volume (30 Days)
99.0K
★ 549.6K
Earning Date
10-20-2026
11-03-2026
Dividend Yield
★ 2.64%
N/A
EPS Growth
10.95
★ 56.93
EPS
★ 4.21
N/A
Revenue
N/A
★ $89,063,000.00
Revenue This Year
$16.34
$30.06
Revenue Next Year
$7.39
$27.51
P/E Ratio
$14.37
★ N/A
Revenue Growth
N/A
★ 36.09
52 Week Low
$43.40
$13.20
52 Week High
$63.41
$28.89

Technical Indicators

Market Signals
Indicator
MBWM
CBLL
Relative Strength Index (RSI) 49.24 48.49
Support Level $56.97 $22.73
Resistance Level $62.64 $28.50
Average True Range (ATR) 1.40 1.59
MACD -0.03 -0.22
Stochastic Oscillator 16.29 62.19

Price Performance

Historical Comparison
MBWM
CBLL

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

About CBLL CeriBell Inc.

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Share on Social Networks: